AnaptysBio, Inc. (LON:0HFQ)
London · Delayed Price · Currency is GBP · Price in USD 36.36
-0.18 (-0.50%)
At close: Oct 31, 2025
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of 779.75 million as of November 3, 2025. Its market cap has decreased by -3.23% in one year.
Market Cap
779.75M
Enterprise Value
841.23M
Revenue
89.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.36
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from 245.54M to 779.75M, an increase of 217.57%. That is a compound annual growth rate of 14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 779.75M | 142.31% |
| Dec 31, 2024 | 321.81M | -27.99% |
| Dec 29, 2023 | 446.90M | -38.89% |
| Dec 30, 2022 | 731.27M | 3.07% |
| Dec 31, 2021 | 709.46M | 64.74% |
| Dec 31, 2020 | 430.66M | 29.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 191.73B |
| HSBC Holdings | 182.60B |
| Shell | 164.27B |
| Unilever | 114.25B |
| Rolls-Royce Holdings | 98.20B |
| Rio Tinto Group | 93.27B |
| British American Tobacco p.l.c. | 84.99B |
| GSK plc | 71.57B |